Your browser doesn't support javascript.
loading
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
Pich, A; Riera, L; Sismondi, F; Godio, L; Davico Bonino, L; Marmont, F; Francia di Celle, P.
Affiliation
  • Pich A; Department of Biomedical Sciences and Human Oncology, Section of Pathology, University of Turin, Turin, Italy. achille.pich@unito.it
J Clin Pathol ; 62(9): 798-801, 2009 Sep.
Article in En | MEDLINE | ID: mdl-19734476
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelomonocytic, Chronic / Janus Kinase 2 / Mutation Type of study: Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pathol Year: 2009 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelomonocytic, Chronic / Janus Kinase 2 / Mutation Type of study: Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pathol Year: 2009 Document type: Article Affiliation country: Italia Country of publication: Reino Unido